Oct
04
Clinical Trial – Evaluate an Autologous Vaccine Plus Adoptive T-Cell Transfer in the Treatment of Dogs with and Hemangiosarcoma
A Funded Clinical Trial to Evaluate an Autologous Vaccine Plus Adoptive T-Cell Transfer in the Treatment of Dogs with and Hemangiosarcoma Trial Specifics: Animal Clinical Investigations is conducting a clinical trial in dogs with hemangiosarcoma, sponsored by Elias Animal Health, LLC. ELIAS Cancer Immunotherapy (ECI™) is a personalized T cell-based treatment that triggers the patient’s... Learn More
